Avon Foundation Breast Cancer Research Program Request for Proposals
The Avon Foundation for Women continues to seek new preventive strategies to address the growing number of breast cancer cases around the globe. To develop new strategies to prevent breast cancer we need to understand the causes of breast cancer in women, changes in breast cells that give rise to cancer, markers for disease, and how breast cancer progresses. The 2011 Avon Foundation Research Program seeks proposals in these areas to advance understanding of causes of breast cancer and prevention.
How to Apply:
For 2011, there are two receipt dates outlined below (review cycles) and a 2-stage application process:
(i) Stage 1: Letter-of-Intent (LOI) – Open to all research organizations: universities, nonprofit organizations, or in rare instances, for-profit organizations.
(ii) Stage 2: Full Proposal – By invitation only based on the review of your LOI submission.
A Letter of Intent is completed using the online system.
Letter of intent due due date Cycle 1: January 21, 2011
Letter of intent due date Cycle 2: May 6, 2011
Proposals may request up to $150,000 total costs per year (this limit is inclusive of 10% indirect costs), for up to 2 years in duration. Thus, the total award budget can be up to $300,000 to cover up to 2 years duration. Applications involving multiple institutions or collaborators in need of a higher level of funding may contact the Avon Foundation to inquire whether an increased amount may be requested. A detailed budget and budget justification are required in the online application.
Research questions we hope to answer to further the development of breast cancer prevention strategies include, but are not limited to, the following:
* Understanding the potential causes of breast cancer and research to develop new preventative strategies
* Understanding the role of endogenous and exogenous environmental factors in the development of breast cancer
* Understanding whether viruses or infectious agents play a role in breast cancer
* Validation of markers/biomarkers of breast cancer risk or that signal different breast states such as parous vs. nulliparous breast (Note: we do not support discovery research. Our funds are directed towards validation, translation or clinical application of markers)
* Development of clinically applicable assays or diagnostic tests that are predictive of breast cancer risk or that can be used to monitor changes in breast over time (for example, differentiating healthy breast vs. ADH vs. DCIS vs. IDC)
* Understanding how parity and breastfeeding alter breast cancer risk
Avon Foundation for Women Contacts
The Avon Foundation for Women is based at the Avon Global Headquarters in New York City.
Avon Foundation for Women
1345 Avenue of the Americas
New York, NY 10105-0196
For general inquiries, please email firstname.lastname@example.org.